期刊文献+

中药活性成分防治脑缺血特点分析 被引量:6

Characteristics Analysis of Chinese Medicine Active Components Preventing and Treating Cerebral Ischemia
下载PDF
导出
摘要 目的:探讨中药活性成分防治脑缺血的特点及机制。方法:归纳各类中药活性成分对脑缺血模型的作用及防治脑缺血的特点,总结各类中药活性成分防治脑缺血的共性机制。结果:防治脑缺血的中药多为活血化瘀类、清热解毒类,各类中药活性成分防治脑缺血的机制有共通之处。结论:不同种类的中药活性成分防治脑缺血的机制对筛选特效药物具有重要意义。 Objective:To discuss the characteristics and mechanisms of Chinese medicine active components preventing and treating cerebral ischemia.Methods:Induced activities of Chinese medicine active components on cerebral ischemia model and characteristics of preventing cerebral ischemia,and summed up common mechanisms of Chinese medicine active components preventing and treating cerebral ischemia.Results:Much of the TCM which can prevent and treat cerebral ischemia are TCM of promoting blood circulation and removing blood stasis and TCM of clearing heat and detoxicating,and there are commonality for mechanisms among various types of Chinese medicine active components preventing and treating cerebral ischemia.Conclusion:Mechanisms of different types of Chinese medicine active components preventing and treating cerebral ischemia have important significance to screen specific drugs.
机构地区 河南中医学院
出处 《中医学报》 CAS 2013年第8期1184-1187,共4页 Acta Chinese Medicine
基金 教育部科技攻关项目(编号:211104) 河南省高校科技创新团队项目(编号:2012IRTSTHN011) 省院合作项目(编号:102106000022) 河南中医学院科技创新团队计划项目(编号:2010XCXTD03)
关键词 脑缺血 中药活性成分 活血化瘀 清热解毒 cerebral ischemia Chinese medicine active components promoting blood circulation and removing blood stasis clearing heat and detoxicating
  • 相关文献

参考文献26

二级参考文献290

共引文献557

同被引文献73

  • 1脑卒中筛查与防治技术规范[J].中国医学前沿杂志(电子版),2013,5(9):44-50. 被引量:115
  • 2胡建鹏,王键,吴玲,郜峦,李净.脑络欣通对脑缺血再灌注气虚血瘀证大鼠皮质、海马CA_1区FADD和Caspase-3蛋白表达的影响[J].中国中医药科技,2006,13(1):11-13. 被引量:12
  • 3Moorhouse P, Rockwood K. Vascular cognitive impairment: current concepts and clinical developments[J]. Lancet Neurol, 2008, 7(3): 246-255.
  • 4Thai DR, Grinberg LT, Attems J. Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain[J]. Exp Gerontol, 2012, 47(11): 816-824.
  • 5Baskys A, Cheng IX. Pharmacological prevention and treatment of vascular dementia: approaches and perspectives[J]. Exp Gerontol, 2012, 47(11): 887-891.
  • 6Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippoca-mpal neurogenesis affect learning and memory[J]. Nat Rev Neurosci, 2010, 11(5): 339-350.
  • 7Jiwa NS, Garrard P, Hainsworth AH. Experimental models of vascular dementia and vascular cognitive impairment: a systematic review[J]. J Neurochem, 2010, 115(4): 814-828.
  • 8Gupta S, Sharma B, Singh P, et al. Modulation of transient receptor potential vanilloid subtype I (TRPVI) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular dementia[J]. Curr Neurovasc Res, 2014, 11(2): 94-106.
  • 9Li H, Xie YH, Yang Q, et al. Cardioprotective effect ofpaeonol and danshensu combinati-on on isoproterenol-induced myocardial injury in rats[J]. Plos One, 2012, 7(11): e48872.
  • 10Hu S, Shen G, Zhao W, et al. Paeonol, the main active principles of paeonia moutan, ameliorates alcoholic steatohepathis in mice [J]. J Ethnopharmacol, 2010, 128(1): 100-106.

引证文献6

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部